Why the study?
Does long-term treatment with verapamil or nifedipine reduce left ventricular mass and preserve systolic function in hypertensive patients?
Does long-term treatment with verapamil or nifedipine reduce left ventricular mass and preserve systolic function in hypertensive patients?
Answers are grounded in this paper and cite their sources.
Long-term monotherapy with verapamil or nifedipine in hypertensive patients significantly reduces left ventricular hypertrophy while preserving systolic function.
Summary: The aim of this study was to assess the effects of chronic antihypertensive treatment with verapamil and nifendipine on left ventricular (LV) anatomy and function, also in relation to adrenergic activity and β-adrenergic sensitivity. In fact, it is known that, during antihypertensive treatment, changes of LV mass and function may be affected also by the level of adrenosympathetic tone. Blood pressure (BP), heart rate (HR), plasma catecholamines (pCA), β-adrenergic responsiveness to isoproterenol (dose that increased HR by 25 beats/min = CD25), LV mass as well as systolic function (2D-guided M-mode echo), at rest and during stress (handgrip test [HG], 30% max, for 3 min), were measured on placebo, after 1 and 6 months of monotherapy with verapamil (VER, 240 mg/day, 9 patients) or nifedipine (NIF, 40 mg/day, 10 patients). Both treatments significantly reduced BP (p < 0.05 at least). HR, pCA, and cardiac output did not change during treatment with VER, whereas they were slightly but significantly increased during treatment with NIF (p < 0.05 at least). CD25 was significantly increased during treatment with VER (p < 0.05) but not during treatment with NIF. Both treatments induced a significant reduction of LV mass after 6 months (p < 0.01 with VER and p < 0.05 with NIF). The correlation between LV end-systolic stress (ESS) and LV shortening fraction (SF) was used to determine whether any change in cardiac performance concomitant with reduction in LV mass was appropriate or exceeded changes in LV wall stress; in fact, no point of relation between SF and ESS during treatment, both at rest and at 3 min of HG test, was below 95% prediction limits of the correlation obtained in normal volunteers. In conclusion, long-term treatment with both VER and NIF is associated with well-preserved LV systolic performance. VER and NIF have an opposite effect on adrenergic activity and β-adrenergic sensitivity. Both VER and NIF may induce a significant regression of LV hypertrophy.
No takes yet. Share an insight, caveat, or question.
Agabiti-Rosei et al. (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: